Beth Kramli

Beth has 20 years of communications experience in the pharmaceutical and consumer healthcare markets. She has counseled leading pharmaceutical companies on developing brand and disease awareness campaigns, cultivating third-party relationships and building winning media strategies.

Her areas of expertise span strategic planning and program development, project, event and people management, writing and material development, internal communications and third-party and spokesperson relations. In addition, Beth has successfully built sports focused partnerships for her pharmaceutical clients, helping them to leverage sports media plus the fan bases of professional athletes and teams to grow market and mind share.

She has a worked in a broad variety of disease areas including cardiovascular, men’s health, women’s health, dermatology, oral care, gastroenterology, CNS, hematology and respiratory health. During her career, Beth has managed brands such as Zocor, Cozaar, Propecia, ProQuad, Varivax, Zyrtec, INSPRA, Relpax, Detrol, Toviaz, Listerine, BeneFIX, ReFacto, AcipHex, Deflux and agomelatine. She has also worked in-house for leading pharmaceutical companies.

Before beginning her consulting career with King PR, Beth worked at Marina Maher Communications (MMC) as a senior vice president in the firm’s Healthcare Practice. Prior to joining MMC, Beth spent six years working for Ogilvy Public Relations and its sister-company, Feinstein Kean Healthcare (FKH). She was tapped by FKH and Ogilvy PR senior leadership to open a second FKH office in New Jersey to help better service clients in the tri-state area and explore new business opportunities. Beth was responsible for identifying and cultivating opportunities for business growth including creating awareness for the FKH brand and establishing a network of relationships. Beth joined Ogilvy PR from BSMG (currently WeberShandwick), where she was a director.

Beth received a bachelor of arts degree in communications from the University of Delaware.